UNSPSC 51352207: Diethylstilbestrol diphosphate

This classification denotes a hormonal antineoplastic agent with the molecular formula C18H22O8P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0E0NMA80F, chemically known as 4,4-stilbenediol, .alpha., .alpha.-diethyl-, diphosphate, disodium salt but more generally known as fosfestrol, which bears US NIH Compound Identifier 3032325. European Medicines Agency schedules Fosfestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07795MIG.

UNSPSC 51352207 Diethylstilbestrol diphosphate is a Commodity code covering a pharmaceutical active ingredient with limited contemporary state and local procurement activity. The source provides no records of recent state or local contract opportunities soliciting this substance.

Diethylstilbestrol diphosphate (DES diphosphate) is a synthetic estrogen historically used in veterinary and human medicine, though its use has contracted significantly in most jurisdictions due to regulatory restrictions and clinical obsolescence. State and local governments do not appear to be active buyers of this pharmaceutical ingredient in the current procurement environment. Without recent solicitation data, no geographic concentration, issuing-body patterns, or representative opportunities can be characterized.